
- Oncology NEWS International Vol 5 No 7
- Volume 5
- Issue 7
PCR-Based HIV Test Monitors Viral Load
BRANCHBURG, NJ--Roche Diagnostic Systems Inc.'s Amplicor H.I.V.-1 monitor test for use in determining viral load in individuals infected with HIV has received FDA approval for marketing. The test uses polymerase chain reaction (PCR) technology to measure HIV genetic material in the blood.
BRANCHBURG, NJ--Roche Diagnostic Systems Inc.'s Amplicor H.I.V.-1monitor test for use in determining viral load in individualsinfected with HIV has received FDA approval for marketing. Thetest uses polymerase chain reaction (PCR) technology to measureHIV genetic material in the blood.
In laboratory studies, the Amplicor test was able in some casesto detect as few as 400 copies of HIV DNA in a blood sample andcould regularly detect 800 or more copies.
Two clinical trials of Amplicor were conducted in patients withadvanced HIV infection who had received no antiviral treatmentor treatment for less than 16 weeks. The results showed that highviral load before anti-HIV therapy, or large increases in viralload after treatment, correlated with increased risk of diseaseprogression to full-blown AIDS.
Articles in this issue
over 29 years ago
Princess Diana Helps Raise Over $1 Million for Cancer Researchover 29 years ago
Study Gives Terminal Patients Option: $18,000 or More Treatmentover 29 years ago
Proven: Colorectal Screening Cuts Deaths 50%over 29 years ago
Virtual Colonoscopy Technique Feasible in Detecting Polypsover 29 years ago
Trimetrexate Appears Beneficial in Colorectal Cancerover 29 years ago
FDA Liaison Program Answers Patients' Questions About Trialsover 29 years ago
New Company Joins With RPR To Develop Intrabody Technologyover 29 years ago
More Insurers Covering ABMT, Despite Lack of Efficacy Dataover 29 years ago
CDC Says Teen Smoking Still RisingNewsletter
Stay up to date on recent advances in the multidisciplinary approach to cancer.